Pulse Biosciences, Inc. (PLSE)

Pulse Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	977	673	103	439	605	279
Market Cap Growth	280.82%	552.72%	-76.50%	-27.42%	116.90%	43.21%
Enterprise Value	951	638	118	421	596	260
PE Ratio	-	-15.95	-1.76	-6.89	-12.13	-5.93
PS Ratio	-	-	147.32	309.48	-	-
PB Ratio	26.93	15.17	-45.87	12.30	26.41	9.07
P/FCF Ratio	-13.24	-20.30	-2.17	-8.05	-16.89	-8.01
P/OCF Ratio	-13.27	-20.37	-2.19	-8.11	-17.10	-8.15
EV/Sales Ratio	-	-	168.49	297.23	-	-
EV/EBITDA Ratio	-10.76	-15.06	-2.08	-6.81	-12.19	-5.80
EV/EBIT Ratio	-10.46	-14.64	-2.03	-6.69	-11.92	-5.66
EV/FCF Ratio	-12.52	-19.24	-2.49	-7.73	-16.63	-7.48
Debt / Equity Ratio	0.25	0.21	-33.79	0.32	0.50	0.22
Debt / EBITDA Ratio	-0.21	-0.22	-1.34	-0.18	-0.23	-0.15
Debt / FCF Ratio	-0.24	-0.28	-1.60	-0.21	-0.32	-0.19
Quick Ratio	6.87	6.61	10.22	3.37	2.70	5.70
Current Ratio	7.06	6.76	10.39	4.30	2.95	5.92
Asset Turnover	0	0	0.01	0.02	0	0
Interest Coverage	-	-	-129.59	-97.54	-	-46.78
Return on Equity (ROE)	-88.00%	-115.40%	-486.00%	-156.00%	-166.60%	-104.00%
Return on Assets (ROA)	-68.30%	-62.50%	-95.30%	-90.30%	-110.00%	-89.00%
Return on Capital (ROIC)	-98.77%	-81.44%	-78.77%	-134.24%	-145.88%	-128.03%
Earnings Yield	-4.35%	-6.27%	-56.73%	-14.51%	-8.24%	-16.85%
FCF Yield	-3.72%	-4.93%	-45.98%	-12.43%	-5.92%	-12.48%
Buyback Yield / Dilution	-47.56%	-41.56%	-21.35%	-20.29%	-12.06%	-21.48%
Total Shareholder Return	-47.56%	-41.56%	-21.35%	-20.29%	-12.06%	-21.48%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).